Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel O Villarreal

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Opinion in Immunology|April 26, 2014
Interleukin 33: a switch-hitting cytokineDaniel O Villarreal, David B Weiner
Expert Review of Vaccines|February 7, 2015
IL-33 isoforms: their future as vaccine adjuvants?Daniel O Villarreal, David B Weiner
Human Vaccines & Immunotherapeutics|June 20, 2015
Alarmin IL-33 elicits potent TB-specific cell-mediated responsesDaniel O Villarreal, Rebekah J Siefert, David B Weiner
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
DNA Vaccines: A Strategy for Developing Novel Multivalent TB VaccinesJaemi S Chu, Daniel O Villarreal, David B Weiner
Human Vaccines & Immunotherapeutics|June 21, 2016
A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosisKristin L Griffiths, Daniel O Villarreal, David B Weiner, et al.
Advances in Experimental Medicine and Biology|March 12, 2015
Synthetic DNA approach to cytomegalovirus vaccine/immune therapyStephan J Wu, Daniel O Villarreal, Devon J Shedlock, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCGDaniel O Villarreal, Jewell Walters, Dominick J Laddy, et al.
Oncotarget|April 8, 2017
Combination GITR targeting/PD-1 blockade with vaccination drives robust antigen-specific antitumor immunityDaniel O Villarreal, Diana Chin, Melissa A Smith, et al.
Vaccines|May 25, 2019
Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in a Lethal Challenge ModelLumena Louis, Megan C Wise, Hyeree Choi, et al.
Expert Review of Vaccines|May 11, 2013
Synthetic DNA vaccine strategies against persistent viral infectionsDaniel O Villarreal, Kendra T Talbott, Daniel K Choo, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Opinion in Immunology|April 26, 2014
Interleukin 33: a switch-hitting cytokineDaniel O Villarreal, David B Weiner
Expert Review of Vaccines|February 7, 2015
IL-33 isoforms: their future as vaccine adjuvants?Daniel O Villarreal, David B Weiner
Human Vaccines & Immunotherapeutics|June 20, 2015
Alarmin IL-33 elicits potent TB-specific cell-mediated responsesDaniel O Villarreal, Rebekah J Siefert, David B Weiner
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
DNA Vaccines: A Strategy for Developing Novel Multivalent TB VaccinesJaemi S Chu, Daniel O Villarreal, David B Weiner
Human Vaccines & Immunotherapeutics|June 21, 2016
A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosisKristin L Griffiths, Daniel O Villarreal, David B Weiner, et al.
Advances in Experimental Medicine and Biology|March 12, 2015
Synthetic DNA approach to cytomegalovirus vaccine/immune therapyStephan J Wu, Daniel O Villarreal, Devon J Shedlock, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCGDaniel O Villarreal, Jewell Walters, Dominick J Laddy, et al.
Oncotarget|April 8, 2017
Combination GITR targeting/PD-1 blockade with vaccination drives robust antigen-specific antitumor immunityDaniel O Villarreal, Diana Chin, Melissa A Smith, et al.
Vaccines|May 25, 2019
Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in a Lethal Challenge ModelLumena Louis, Megan C Wise, Hyeree Choi, et al.
Expert Review of Vaccines|May 11, 2013
Synthetic DNA vaccine strategies against persistent viral infectionsDaniel O Villarreal, Kendra T Talbott, Daniel K Choo, et al.
Pageof 3